< Back to latest news & events

UPC

Green Light from AG Bot for Unitary Patent in Europe

November 2014

The Opinion of Advocate General Bot, regarding Spain’s actions (CJEU cases C-146/13 and C-147/13) that the Regulations surrounding the creating of the European Unitary Patent should be annulled, has been given today. It is the Opinion of AG Bot that the CJEU should dismiss Spain’s actions.

Spain pleaded that the proposed language scheme would be discriminatory to persons whose mother tongue was not German, French or English. Furthermore, that aspects of EU law had been breached in the arranging of the Regulation on the Unitary Patent and Unified Patent Court.

Today’s press release states that unitary protection “brings real benefit” over the current European Patent Convention, where the effects of European patents are determined by national laws. Furthermore, even though the language arrangements that have been selected under the regime may curtail the use of some European languages, they “pursue a legitimate objective of reducing translation costs”. To limit the number of languages for the European Unitary Patent will reduce costs, and furthermore, acknowledges the linguistic realities of the patent sector (German, French and English are the most popular spoken languages from which patent application in the EU originate, as well as the languages of most published scientific papers).

In both cases brought by Spain, AG Bot proposed that CJEU should dismiss Spain’s actions.

The opinion of the Advocate General is not binding on the CJEU, and judgements will be given at a later stage. However, it is unusual for the Court not to follow the Opinion of the AG. The Opinion signifies a green light for unitary patent protection in Europe.

Latest updates

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article

HGF Highly Ranked in Legal 500 2026

The Legal 500 UK 2026 rankings have been released and HGF has once again been ranked across several regions and practice areas. HGF continue to be ranked in the Top-Tier …

Read article

12 HGF Attorneys Recognised as Managing IP Rising Stars 2025

We are very proud to announce that 12 of our attorneys have been recognised as Rising Stars in the latest Managing IP Rankings! This accolade celebrates the next generation of …

Read article

IP Ingredients: The companies making – and patenting - alt coffee

How do you like your coffee? Frothy or flat? Milky or black? Oat-milk or soy?  How about coffee which isn’t derived from coffee beans? Coffee is the second most traded …

Read article